Evidence map›Paper›PMID 29691440›Full record

ArticleScientific reports2018

Maternal imprinting on cognition markers of wild type and transgenic Alzheimer's disease model mice.

Marta Zamarbide, Francisco J Gil-Bea, Paul Bannenberg, Eva Martínez-Pinilla, Juan Sandoval, Rafael Franco, Alberto Pérez-Mediavilla

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Imprinted Genes and Multiple Sclerosis: What Do We Know?International journal of molecular sciences · 2021
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marta ZamarbideNeuroscience Department, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain. zamarbidemarta@gmail.com.
Francisco J Gil-BeaNeuroscience Department, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.
Paul BannenbergNeuroscience Department, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.
Eva Martínez-PinillaNeuroscience Department, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.
Juan SandovalLaboratory of personalized medicine, Epigenomics Unit, Medical Research Institute La Fe, Valencia, Spain.
Rafael FrancoLaboratory of Molecular Neurobiology, Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Barcelona, Spain.
Alberto Pérez-MediavillaNeuroscience Department, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The risk of suffering from Alzheimer's disease (AD) is higher in individuals from AD-affected mothers. The purpose of this investigation was to study whether maternal transmission might produce AD-related alterations in progenies of mice that do not have any genotypic alteration. We used cognitively-intact mothers harbouring in heterozygosity the transgene for overexpressing the Swedish double mutant version of the human amyloid precursor protein (hAβPPswe). The phenotype of the offspring with or without the transgene resulting from crossing young Tg2576 females with wild-type males were compared with those of the offspring resulting from crossing wild-type females with Tg2576 males. The hAβPPswe-bearing offspring from Tg2576 mothers showed an aggravated AD-like phenotype. Remarkably, cognitive, immunohistochemical and some biochemical features displayed by Tg2576 heterozygous mice were also found in wild-type animals generated from Tg2576 females. This suggests the existence of a maternal imprinting in the wild-type offspring that confers a greater facility to launch an AD-like neurodegenerative cascade. Such progeny, lacking any mutant amyloid precursor protein, constitutes a novel model to study maternal transmission of AD and, even more important, to discover early risk markers that predispose to the development of AD.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAnimalsBiomarkersBrainCognitionDisease Models, AnimalFemaleGenomic ImprintingHumansMaleMaze LearningMiceMice, Inbred C57BLMice, TransgenicAmyloid beta-PeptidesAmyloid beta-Protein PrecursorBiomarkers

Identifiers

PMID29691440
PMCPMC5915602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.